發送短信 : Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC Patients treated with first-line intercalated erlotinib and chemotherapy

 __   _      ___       _____    _____     _____   
| || | ||   / _ \\    / ___//  |  ___||  / ____|| 
| '--' ||  / //\ \\   \___ \\  | ||__   / //---`' 
| .--. || |  ___  ||  /    //  | ||__   \ \\___   
|_|| |_|| |_||  |_|| /____//   |_____||  \_____|| 
`-`  `-`  `-`   `-` `-----`    `-----`    `----`